While analyzing the GBM cohort separately abolished the prognostic significance of EGFR mutations (Figure 2—figure supplement 4D), EGFR amplifications remained associated with outcome in both the LGG and GBM cohorts (Figure 2—figure supplement 4B–C). Here, EGFR is linked to glioblastoma.